2010年本科毕业于北京理工大学生命学院，2014年在加拿大萨斯喀彻温大学医学院获得药理学博士学位。博士毕业后于加拿大渥太华心脏研究所及多伦多大学从事博士后研究，导师是加拿大权威的心血管病医生，多伦多大学医学院教授Peter Liu。主要从事心脏病病理及免疫学的研究。目前研究内容主要包括探究重要免疫因子信号通路在心脏疾病发病机制中的关键作用，以及利用蛋白质组学方法筛选心脏病理条件下的生物标记蛋白。2021年被引进，任中科中山药物创新研究院研究员、课题组长、科研发展部部长。

心脏药理学，心脏病理学，免疫学，线粒体代谢功能；探究重要免疫因子信号通路在心脏疾病发病机制中的关键作用，以及利用蛋白质组学方法筛选心脏病理条件下的生物标记蛋白。

1.探究重要免疫因子信号通路在心脏疾病发病机制中的关键作用，以及利用蛋白质组学方法筛选心脏病理条件下的生物标记蛋白，研究心脏病病理药理机制，获得学界认可。
2.被评选为加拿大心血管病学会（CCS）2012年度20名优秀青年科研者之一，并授予Have A Heart Bursary，成为了加拿大心血管协会的一员，是近年来唯一获奖的中国籍学者。
3.2017年研究成果获得欧洲心脏病学会（ESC）的优秀青年科研者奖。
4.2016/08 中国科学院“海外人才走进科学院”优秀青年学者。
5.2014/06 国家优秀自费留学生奖学金。

1. Han-Bin Lin, PhD and Peter P. Liu, MD. (2020). COVID-19 and the Heart, ACE2 Level and the Company it Keeps Hold the Key. JACC: Basic to Translational Science. 5(9): 884-887.

2. Han-Bin Lin, PhD; Kotaro Naito, MD, PhD; Yena Oh, MSc, Gedaliah Farber; BHSc, Georges Kanaan, PhD, Alan Valaperti, PhD; Fayez Dawood, DVM; Liyong Zhang, PhD; Guo Hua Li, MD, PhD; David Smyth, PhD; Mark Moon, MSc; Youan Liu, MD; Wenbin Liang, PhD; Benjamin Rotstein, PhD; Dana Philpott, PhD; Kyoung-Han Kim, PhD; Mary-Ellen Harper, PhD; Peter P Liu, MD. (2020). Innate immune Nod1/RIP2 signaling is essential for cardiac hypertrophy, - but requires mitochondrial antiviral signaling protein (MAVS) for signal transductions and energy balance. Circulation In press, https://doi.org/10.1161/CIRCULATIONAHA.119.041213

3. Michael A. J. Moser, Steve Arcand, Han-Bin Lin, Chris Wojnarowicz, Jolanta Sawicka Tamalina Banerjee, Yigang Luo, Gavin R. Beck, Patrick P. Luke, and Grzegorz Sawicki. (2016). Protection of the Transplant Kidney from Preservation Injury by Inhibition of Matrix Metalloproteinases.PLoS One. 11(6): 0-0.

4. Iwona Bil-Lula, Han-Bin Lin, Dariusz Biay, Magdalena Wawrzyska, Lucas Diebel, Jolanta Sawicka, Mieczyslaw Wo?niak, Grzegorz Sawicki. (2016). Subthreshold nitric oxide synthase inhibition improves synergistic effects of subthreshold MMP-2/MLCK-mediated cardiomyocyte protection from hypoxic injury. Journal of Cellular and Molecular Medicine. 20(6): 1086–1094.

5. Han-Bin Lin, Virgilio J. J. Cadete, Bikramjit Sra, Jolanta Sawicka, Zhicheng Chen, Lane K. Bekar, Francisco Cayabyab, Grzegorz Sawicki. (2014). Inhibition of MMP-2 expression with siRNA increases baseline cardiomyocyte contractility and protects against simulated ischemic reperfusion injury. BioMed Research International. 2014: 11.

6. Han-Bin Lin, Keshav Sharma, Dariusz Bialy, Magdalena Wawrzynska, Randy Purves, Francisco Cayabyab, Mieczyslaw Wozniak, Grzegorz Sawicki. (2014). Inhibition of MMP-2 expression affects the levels of metabolic enzymes: Proteomic analysis of rat cardiomyocytes. Journal of Proteomics. 106(25): 74-85.

7. Virgilio J. J. Cadete, Steven Arcand, Han-Bin Lin, Grzegorz Sawicki. (2013). Synergy in protection against cardiac ischemia/reperfusion injury: a novel therapeutic paradigm for the future. Future Medicinal Chemistry. 5(4): 389-398.

8.Cadete Virgilio JJ*, Lin Han-Bin*, Sawicka Jolanta, Wozniak Mieczyslaw, Sawicki Grzegorz. (2012). Proteomic analysis of right and left cardiac ventricles under aerobic conditions and after ischemia/ reperfusion.Proteomics. 12(14): 2366-2377.

9. Lin Han-Bin, Cadete Virgilio JJ, Sawicka Jolanta, Wozniak Mieczyslaw, Sawicki Grzegorz. (2012). Effect of the myosin light chain kinase inhibitor ML-7 on the proteome of hearts subjected to ischemia/reperfusion injury. Journal of Proteomics. 75(17): 5386-5395.